Cartesian Therapeutics Inc - RNAC - stock price prediction, stock price target, analyst ratings from 7 analysts

Cartesian Therapeutics Inc has a share price target of US$ 34, revenue growth forecast of -85.0%, and profit growth estimate of 32.4% for FY26, based on top 7 analyst calls.